Journal profile

Rheumatology

Publisher: Oxford University Press
ISSN1462-0324 | 1462-0332 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.69
Citation rate 2.61 5,322 total citations
h5-index 67 h5 depth signal
Cited share 53.3% 1,128 of 2,115
Total citations 5,322 Citation footprint
Metric signal 2.89 External metric anchor
Self-citation 6.2% 332 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United Kingdom 6,016
United States 2,033
Italy 928
France 818
Netherlands 783

Citing Fields of Research

Musculoskeletal Disorders 7,928
Auto-Inflammatory Disorders 4,904
Immunology 1,200
Hematology 616
Osteopathies 437

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 28,691 Articles tracked across the journal lifetime
Indexed publication set 2,115 1,128 cited publications
Last 12 months 1,117 93.1 publications/month
Open access share 24.3% 271 OA publications in the last year
Leading citing country United Kingdom 6,016 citing publications
Leading citing field Musculoskeletal Disorders 7,928 citing publications
Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v38n1, Jan. 1999-
PubMed
v38n1, Jan. 1999-
Abridged index medicus
Active Coverage
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Musculoskeletal Disorders Auto-Inflammatory Disorders

Issuing & Sponsoring Bodies

Contributor
British Society for Rheumatology

Broad Categories

Rheumatology Musculoskeletal Disorders Auto-Inflammatory Disorders

MeSH Descriptors

Rheumatic Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Claire Adams, Marie-Eve Carrier, Meira Golberg et al.
Objective: Health literacy reflects the ability to find, understand, evaluate, and use information to make health-related decisions. We evaluated sociodemographic and disease factors associated with health literacy among people with syst...
02
Motomu Hashimoto, Masao Katsushima, Fabienne Mackay et al.
Systemic autoimmune diseases arise from a heterogeneous interplay of genetic, epigenetic, and environmental factors that culminates in loss of tolerance, chronic inflammation, and tissue injury. Among the pathways linking susceptibility ...
03
Oh Chan Kwon, Hye Sun Lee, So Young Jeon et al.
Objective: To compare the risk of major adverse cardiovascular events (MACE) between tumor necrosis factor inhibitors (TNFi) and Janus kinase inhibitors (JAKi) when initiated as first-line advanced therapy in patients with rheumatoid art...
06
Shuwei Li, Xiaofeng Zhou, Zhechen Liu et al.
The clinical course of gout is typically divided into four stages: asymptomatic hyperuricemia, gout flares, intercritical gout and tophaceous gout. However, the cellular and molecular mechanisms driving transitions between these stages r...

Bibliographical & Catalog Notes

Title from cover.

Latest issue consulted: Vol. 38, no. 2 (Feb. 1999).

Also issued online.

Issued also on 16 mm. and 35 mm. microfilm and microfiche by University Microfilms Inc.

Official journal of: British Society for Rheumatology.